Pioneering memory researcher Brenda Milner inducted into the Canadian Science and Engineering Hall of Fame
November 21 2012 - Dr. Brenda Milner, pioneer in the field of cognitive neuroscience whose discoveries revolutionized the understanding of memory, is being inducted into the Canadian Science and Engineering Hall of Fame today. The induction ceremony takes place at the Canada Science and Technology Museum in Ottawa. Other inductees are physicist and educator Dr. Ursula Franklin and aviation pioneer J.A.D. McCurdy.
November 8 2012 - After a worldwide search, the renowned Montreal Neurological Institute and Hospital – The Neuro – of McGill University and the McGill University Health Centre has a new director, Guy Rouleau, MD, PhD, FRCPC, OQ. Dr. Rouleau, a prominent Quebec clinician-scientist recognized for his contributions to science and society, will also hold the Wilder Penfield Chair in Neuroscience as Professor of Neurology and Neurosurgery at McGill.
Un événement commun se produit dans maintes pathologies du système nerveux : des cellules microgliales, qui sont des sentinelles chargées de surveiller, se muent en combattantes. Cellules immunitaires du système nerveux, les microglies ingèrent et détruisent des agents pathogènes et des cellules nerveuses lésées. Bien que ce processus soit crucial dans l’organisme, on savait jusqu’à présent très peu au sujet des mécanismes moléculaires d’activation des microglies.
In many pathologies of the nervous system, there is a common event - cells called microglia are activated from surveillant watchmen into fighters. Microglia are the immune cells of the nervous system, ingesting and destroying pathogens and damaged nerve cells. Until now little was known about the molecular mechanisms of microglia activation despite this being a critical process in the body.
International study with researchers at The Neuro reveals links with other neurodegenerative diseases MONTREAL, October 9, 2012 - Scientists at the Montreal Neurological Institute and Hospital – The Neuro, McGill University working with a team at Oxford University have uncovered the genetic defect underlying a group of rare genetic disorders. Using a new technique that has revolutionized genetic studies, the teams determined that mutations in the RMND1 gene were responsible for severe neurodegenerative disorders, in two infants, ultimately leading to thei
Genes predict the brain’s reaction to smoking Have you ever wondered why some people find it so much easier to stop smoking than others? New research shows that vulnerability to smoking addiction is shaped by our genes. A study from the Montreal Neurological Institute and Hospital - The Neuro, McGill University shows that people with genetically fast nicotine metabolism have a significantly greater brain response to smoking cues than those with slow nicotine metabolism.
Have you ever wondered why some people find it so much easier to stop smoking than others? New research shows that vulnerability to smoking addiction is shaped by our genes. A study from the Montreal Neurological Institute and Hospital - The Neuro, McGill University shows that people with genetically fast nicotine metabolism have a significantly greater brain response to smoking cues than those with slow nicotine metabolism. Previous research shows that greater reactivity to smoking cues predicts decreased success at smoking cessation and that environmental cues promote increased nicotine intake in animals and humans. This new finding that nicotine metabolism rates affect the brain’s response to smoking may lead the way for tailoring smoking cessation programs based on individual genetics.<!--break-->
Two projects led by McGill professors are among the 17 that will receive a total of $28 million over six years to help science and engineering graduates add job skills to their academic achievements, thanks to the Natural Sciences and Engineering Research Council of Canada’s (NSERC) CREATE program.
Creativity, teamwork, determination (possibly accompanied by blood, sweat and tears) are some of the skills honed by grade 6 – 8 students participating in the All Science Challenge, a unique, one-day, highly charged competition hosted by Let’s Talk Science on May 25 at The Neuro- the Montreal Neurological Institute and Hospital of McGill University and the McGill University Health Centre.
“Don’t be safe, be brilliant” a saying by philosopher George Santayana was a favourite of world-renowned scientist Dr. David Colman, late director of the Montreal Neurological Institute and Hospital at McGill University and McGill University Health Centre.
More than 50 members of The Neuro's staff are conducting laboratory and clinical studies related to MS. They employ the finest scientific equipment--from brain imaging scanners to the latest cell biology tools-to study the disease in all its aspects and at every stage. The Neuro's basic scientists and clinical physicians cooperate closely to translate research into patient therapies.